Page 240 - Concise Pathology for Exam Preparation ( PDFDrive )
P. 240

9  Environmental and Nutritional Pathology  225


               enhances immunity and may control free radical production by modulating inflamma-
               tory reactions.

             Q. Write briefly about obesity.
             Ans.  Obesity is defined as abnormal or excessive fat accumulation that presents a risk to
             health. A crude population measure of obesity is the body mass index (BMI)—a person’s
             weight (in kilograms) divided by the square of his or her height (in meters). A person with
             a BMI of 30 or more is generally considered obese. A person with a BMI equal to or more
             than 25 is considered overweight. In children, a healthy weight varies with age and sex.


                          TABLE 9.4.   Definitions of overweight (established
                                       by  World  Health  Organization  and
                                       published in 2000)
                          BMI             Classification
                          ,18.5           Underweight
                          18.5–24.9       Normal weight
                          25.0–29.9       Overweight
                          30.0–34.9       Class I obesity
                          35.0–39.9       Class II obesity
                          40.0           Class III obesity



               The most commonly used definitions, established by the World Health Organization and
             published  in  2000,  provide  values  listed  below  (Table  9.4).  Some  modifications  to  the
             WHO definitions have been made by particular bodies. Any BMI 35 or 40 is severe obesity.
             The neurohumoral mechanisms that regulate the body weight have three components:
               1.  The  afferent  system,  which  generates  humoral  signals.  It  is  constituted  by  leptin
                produced by adipocytes, insulin produced by pancreas and ghrelin produced by the
                endocrine cells of the stomach.
               2.  The central processing unit, located primarily in hypothalamus. It integrates afferent
                signals.
               3.  The effector system, which carries out ‘orders’ from hypothalamic nuclei in the form of
                feeding behaviour and energy expenditure.

             Among the afferent signals, insulin and leptin activate catabolic circuits and inhibit ana-
             bolic pathways. The levels of ghrelin rise sharply before every meal and fall promptly when
             the stomach is ‘filled’. In fact, it is thought that success of gastric bypass surgery in mas-
             sively obese individuals may relate more to the associated suppression of ghrelin levels
             than to an anatomic reduction in stomach capacity. Leptin seems to have a more important
             role than insulin in the CNS control of calorie balance. Adipocytes communicate with the
             hypothalamic centres that control appetite by secreting leptin—a member of the cytokine
             family. When there is an abundance of stored energy in form of adipose tissue, resultant
             high levels of leptin cross blood–brain barrier, binding to leptin receptors. Leptin receptor
             signalling has two effects: it inhibits anabolic circuits that normally promote food intake
             and inhibit energy expenditure. Hence, over a period of time, energy stores (adipocytes)
             are reduced and weight is lost. This, in turn, reduces circulating levels of leptin, and a new
             equilibrium is reached. This cycle is reversed when adipose tissue is lost and leptin levels
             are reduced below a threshold.
               Hypoglycaemia induces release of ghrelin, which acts on neuropeptide Y (NPY) and
             agouti-related peptide (AgRP) neurons in the arcuate nucleus of the hypothalamus. The
             neurotransmitters thus released act on melanin-concentrating hormone (MCH) and orexin
             to increase appetite and induce adipose tissue deposition.
               Overweight and obesity are major risk factors for a number of chronic diseases, includ-
             ing diabetes, metabolic syndrome, cardiovascular diseases and cancer. Once considered a
             problem only in high-income countries, overweight and obesity are now dramatically on
             the rise in low- and middle-income countries; particularly, in the urban settings. Obesity


                                  mebooksfree.com
   235   236   237   238   239   240   241   242   243   244   245